CSIMarket
 


Immunogen inc   (IMGN)
Other Ticker:  
 

Immunogen Inc 's Quick Ratio

IMGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 4.5 below Immunogen Inc average.

Within Major Pharmaceutical Preparations industry 208 other companies have achieved higher Quick Ratio than Immunogen Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 426 to 638.

Explain Quick Ratio?
How much Cash & cash equivalents IMGN´s has?
What are IMGN´s Current Liabilities?


IMGN Quick Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 29.93 % 7.62 % 20.82 % 20.72 % -7.28 %
Y / Y Cash & cash equivalent Change 95.64 % 52.99 % -54.02 % -42.53 % 25.94 %
Quick Ratio MRQ 4.5 6.1 1.98 2.26 2.99
IMGN's Total Ranking # 638 # 426 # 1150 # 522 # 1125
Seq. Current Liabilities Change 43.71 % -7.8 % -16.6 % 17.58 % 19.03 %
Seq. Cash & cash equivalent Change 5.87 % 184.22 % -26.86 % -11.11 % -17.22 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 209
Healthcare Sector # 349
Overall Market # 638


Quick Ratio Statistics
High Average Low
15.16 5.4 1.89
(Sep 30 2012)   (Sep 30 2020)




Financial Statements
Immunogen Inc 's Current Liabilities $ 135 Millions Visit IMGN's Balance sheet
Immunogen Inc 's Cash & cash equivalent $ 606 Millions Visit IMGN's Balance sheet
Source of IMGN's Sales Visit IMGN's Sales by Geography


Cumulative Immunogen Inc 's Quick Ratio

IMGN's Quick Ratio for the trailling 12 Months

IMGN Quick Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 29.93 % 7.62 % 20.82 % 20.72 % -7.28 %
Y / Y Cash & cash equivalent TTM Growth 95.64 % 52.99 % -54.02 % -42.53 % 25.94 %
Quick Ratio TTM 3.66 3.23 2.8 3.52 4.26
Total Ranking TTM # 484 # 3577 # 3855 # 360 # 183
Seq. Current Liabilities TTM Growth 43.71 % -7.8 % -16.6 % 17.58 % 19.03 %
Seq. Cash & cash equivalent TTM Growth 5.87 % 184.22 % -26.86 % -11.11 % -17.22 %


On the trailing twelve months basis IMGN Cash & cash equivalent soared by 95.64 % in III Quarter 2023 year on year, faster than Current Liabilities, this led to increase in in Immunogen Inc 's Quick Ratio to 3.66, Quick Ratio remained below IMGN average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 192 other companies have achieved higher Quick Ratio than Immunogen Inc . While Quick Ratio overall ranking has improved so far to 484, from total ranking during the twelve months ending second quarter 2023 at 3577.

Explain Quick Ratio?
How much Cash & cash equivalents IMGN´s has?
What are IMGN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 193
Healthcare Sector # 340
Within the Market # 484


trailing twelve months Quick Ratio Statistics
High Average Low
6.52 3.8 2.05
(Sep. 30, 2015)   (Sep 30 2021)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Biomea Fusion Inc   12.28 $ 199.090  Millions$ 16.210  Millions
Ligand Pharmaceuticals Incorporated  12.11 $ 190.502  Millions$ 15.727  Millions
Oric Pharmaceuticals Inc   12.00 $ 227.296  Millions$ 18.944  Millions
Anebulo Pharmaceuticals Inc   11.89 $ 8.521  Millions$ 0.717  Millions
Ovid Therapeutics Inc   11.70 $ 87.072  Millions$ 7.439  Millions
Gh Research Plc  11.70 $ 78.420  Millions$ 6.701  Millions
Sensei Biotherapeutics Inc   11.57 $ 72.013  Millions$ 6.226  Millions
Protagonist Therapeutics inc   11.51 $ 320.751  Millions$ 27.867  Millions
Ventyx Biosciences Inc   11.48 $ 300.819  Millions$ 26.208  Millions
Cormedix Inc   11.29 $ 86.587  Millions$ 7.671  Millions
Artelo Biosciences Inc   11.10 $ 10.225  Millions$ 0.921  Millions
Erasca Inc   11.10 $ 296.668  Millions$ 26.730  Millions
Anaptysbio Inc   11.03 $ 413.047  Millions$ 37.437  Millions
Mei Pharma Inc   10.95 $ 82.202  Millions$ 7.509  Millions
Ocuphire Pharma Inc   10.84 $ 42.361  Millions$ 3.909  Millions
Atai Life Sciences N v   10.77 $ 208.994  Millions$ 19.403  Millions
Nkarta Inc   10.75 $ 275.613  Millions$ 25.640  Millions
Lipocine Inc   10.64 $ 23.848  Millions$ 2.241  Millions
Kinnate Biopharma Inc   10.62 $ 167.576  Millions$ 15.774  Millions
Caladrius Biosciences Inc   10.60 $ 54.394  Millions$ 5.132  Millions
Pasithea Therapeutics Corp   10.53 $ 19.680  Millions$ 1.869  Millions
Cryoport inc   10.41 $ 467.518  Millions$ 44.905  Millions
Structure Therapeutics Inc   10.22 $ 205.424  Millions$ 20.091  Millions
Actinium Pharmaceuticals Inc   10.18 $ 82.978  Millions$ 8.150  Millions
89bio Inc   9.99 $ 251.926  Millions$ 25.212  Millions
Lianbio  9.84 $ 252.222  Millions$ 25.627  Millions
Virios Therapeutics Inc   9.82 $ 4.786  Millions$ 0.487  Millions
Annexon Inc   9.63 $ 165.271  Millions$ 17.170  Millions
Syndax Pharmaceuticals Inc   9.54 $ 373.821  Millions$ 39.174  Millions
Milestone Pharmaceuticals inc   9.34 $ 75.746  Millions$ 8.114  Millions

Date modified: 2023-11-03T14:28:07+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com